[Postoperative use of a new hypnotic drug--flunitrazepam]

[Postoperative use of a new hypnotic drug--flunitrazepam] Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

[Postoperative use of a new hypnotic drug--flunitrazepam] Abstract Text:

[Postoperative use of a new hypnotic drug--flunitrazepam] Publishing Authors By Initials

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

[Postoperative use of a new hypnotic drug--flunitrazepam] Journal Published:

PUBLICATION TYPE: Randomized Controlled Trial

Journal: Tidsskrift for den Norske lægeforening : tidsskrif

VOLUME: 94

Page Numbers: 1053-5

Journal Abbreviation: Tidsskr. Nor. Laegeforen.

ISSN: 0029-2001

DAY: 10

MONTH: Jun

YEAR: 1974

[Postoperative use of a new hypnotic drug--flunitrazepam] Information

Number of References:

LANGUAGE: nor

NlmUniqueID: 413423

[Postoperative use of a new hypnotic drug--flunitrazepam] Keywords Mesh Terms:

KEYWORDS: Stimulation, Chemical

MESH TERMS: therapeutic use

Chemical & Substance for Abstract: [Postoperative use of a new hypnotic drug--flunitrazepam] Information

Substance Name: Nitro Compounds

Registry Number: 0

Grant and Affiliation Information for [Postoperative use of a new hypnotic drug--flunitrazepam]

AFFILIATION:

Country: NORWAY

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Tidsskr Nor Laegeforen

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Postoperative use of a new hypnotic drug--flunitrazepam Related Publications

• Acute and long-term effects of exposure to sodium monofluoroacetate (1080) in sheep.
• Bactericidal activity of extended 9-glycyl-amido-minocyclines.
• Circulating human interleukin-8 as an indicator of cancer progression in a nude rat orthotopic human non-small cell lung carcinoma model.
• Design of (Gd-DO3A)(n)-polydiamidopropanoyl-peptide nucleic acid-D(Cys-Ser-Lys-Cys) magnetic resonance contrast agents.
• Drug and medical advertising in Woodville, Miss., 1823-1843.
• Insulin Receptor Substrate 1 Knockdown in Human MCF7 ER+ Breast Cancer Cells by Nuclease-Resistant IRS1 siRNA Conjugated To a Disulfide-Bridged d-Peptide Analogue of Insulin-Like Growth Factor 1.
• Intravenous glucose tests in cases of mongoloidism.
• Motor-defective children.
• Nanotechnology for sensing, imaging, and treating cancer.
• PET imaging of CCND1 mRNA in human MCF7 estrogen receptor positive breast cancer xenografts with oncogene-specific [64Cu]chelator-peptide nucleic acid-IGF1 analog radiohybridization probes.
• Plastic repair of surface defects in preparation for bone grafting.
• Plastic repair of surface defects of the lower extremity.
• Radiohybridization PET Imaging of KRAS G12D mRNA Expression in Human Pancreas Cancer Xenografts with [(64)Cu]DO3A-Peptide Nucleic Acid-Peptide Nanoparticles.
• Receptor-mediated internalization of chelator-PNA-peptide hybridization probes for radioimaging or magnetic resonance imaging of oncogene mRNAs in tumours.
• Two novel biomarkers in developing wood frogs.
• Zebrafish tp53 Knockdown Extends the Survival of Irradiated Zebrafish Embryos More Effectively than the p53 Inhibitor Pifithrin-alpha.
• [A clinical trial with flurazepam (Ro 5-6901) compared with allypropymal]
• [Action of alpha-galactosidases on various sucrose and glucose galactosides.]
• [Action of sucrases on various sucrose galactosides.]
• [Flunitrazepam (R0 5-4200)--a new hypnotic]
• [Flunitrazepam and flurazepam. A comparative study]
• [Hearings of physicians concerning the effects of roentgen rays.]
• [Not Available.]
• [Postoperative use of a new hypnotic drug--flunitrazepam]
• [The Norwegian Poisoning Centre--the first 904 applications]